Martin William Dewhurst - 07 Jan 2026 Form 4 Insider Report for Turn Therapeutics Inc. (TTRX)

Role: Director
Signature: /s/ Zuraiz Chaudhary, attorney-in-fact for Martin William Dewhurst
Issuer symbol: TTRX
Transactions as of: 07 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 04 Feb 2026, 07:31:02 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Dewhurst Martin William	Director	C/O TURN THERAPEUTICS INC., 250 N. WESTLAKE BLVD., WESTLAKE VILLAGE	/s/ Zuraiz Chaudhary, attorney-in-fact for Martin William Dewhurst	04 Feb 2026	0002108597

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TTRX	Common Stock	Award	$0	+21,882		$0.000000	21,882	07 Jan 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities reported in Column 5 of Table I are restricted stock units ("RSU"). Each RSU represents a contingent right to receive one share of common stock, subject to the applicable vesting schedule and conditions of the applicable RSU award and the Issuer's 2025 Omnibus Incentive Plan. The 21,882 RSUs included in Column 5 of Table I vest in full on January 7, 2027, subject to the reporting person's continuous service to the Issuer.

Content

The securities reported in Column 5 of Table I are restricted stock units ("RSU"). Each RSU represents a contingent right to receive one share of common stock, subject to the applicable vesting schedule and conditions of the applicable RSU award and the Issuer's 2025 Omnibus Incentive Plan. The 21,882 RSUs included in Column 5 of Table I vest in full on January 7, 2027, subject to the reporting person's continuous service to the Issuer.